Our Studies

Current Studies Being Conducted

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 YearsAnemia Iron-deficiency1 Month to 17 YearsEnrolling
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II)Major Depressive Disorder 18 Years to 65 YearsEnrolling
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)Irritable Bowel Syndrome With Constipation6 Years to 17 YearsEnrolling
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled AsthmaAsthma12 Years to 80 YearsEnrolling
A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity DisorderAttention-Deficit/Hyperactivity Disorder13 Years to 17 YearsEnrolling
Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying TherapiesDyslipidemias, High Cholesterol, Hypercholesterolemia, Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease18 Years and olderEnrolling
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSDPost-traumatic stress disorder
18 Years to 65 YearsEnrolling
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension Hypertension (Resistant)18 Years to 99 YearsEnrolling
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis.Chronic Obstructive Pulmonary Disease40 Years and olderEnrolling
A Study of CIN-107 in Patients With Uncontrolled Hypertension Receiving 1 Antihypertensive Agent Hypertenstion (Uncontrolled)18 and olderEnrolling